Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.


  1. Advanced Patent Search
Publication numberUS2879784 A
Publication typeGrant
Publication dateMar 31, 1959
Filing dateMar 8, 1954
Priority dateMar 8, 1954
Publication numberUS 2879784 A, US 2879784A, US-A-2879784, US2879784 A, US2879784A
InventorsCutter Fred A
Original AssigneeCutter Lab
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Check valve for the administration of parenteral solutions
US 2879784 A
Previous page
Next page
Description  (OCR text may contain errors)


March 3l, 1959 United States Patent() f 2,879,784 i, Y

CHECK VALVE Eon THE ADMINISTRATION oF PARENTERAL soLUTroNs Fred A. Cutter, Oakland, Calif., assgnor to CutterLaboratories, Berkeley, Calif., a corporation of California This invention relates in general to intravenous solution administering sets, and in particular to improvements in a part adapted to be incorporated in such a set.

There is an increasing tendency toward the use of gas pressure behind intravenous solutions to increase the rate of injection thereof into the veins of a patient. When the amount of solution to be injected into the patients veins is greater than the supply within the solution container, an attendant manually closes a tube leading from the container to the patient just as the container is drained and before the tube is exhausted of liquid to prevent gas from being injected into the patient and causing an air embolism. It is apparent that even infrequent improper action by the attendant would have serious consequences, and it is toward the solution of this problem that the present invention is directed.

It is a primary object of the present invention to provide a device forming a component part of an intravenous solution set and being equipped with a oat check valve arranged to be buoyed up olf its seat 'by liquid owing into said device to allow passage of such liquid through said device toward the patient, but dropping onto its seat upon substantial exhaustion of liquid within said device to prevent the injection of gas into a patients vein.

The invention possesses other advantageous features, some of which with the foregoing will be set forth at length in the following description where the forms of the invention selected for illustration in the drawings accompanying and forming a part of the specification are outlined in full.

In said drawings, two forms of the invention are shown, but it is to be understood that it is not limited to these forms since the invention as set forth in the claim may be embodied in other forms.

Referring to the drawings:

Fig. l is a side elevation of a device embodying the objects of my invention and wherein the lower half thereof is shown in mid-section, the better to illustrate its construction.

Fig. 2 is a side elevation of a modied form of my invention and wherein the lower half is shown in midsection.

The device, as illustrated in Fig. 1, includes an elongated cylindrical chamber, generally entitled 11, formed of an upper section 13 joined to a lower section 15. upper section 13 has an upwardly extending nipple or spike 17 shown as being inserted in the lower end of a `section of tubing 19, by which an intravenous solution is fed to said chamber. Lower section 15 has a closure cap 21 joined to the lower end thereof, and formed on and depending from the cap is a nipple 23, the latter being inserted into the upper end of a tube 25 leading to the patient.' The other or remote end of tu'be 25 has an injection needle thereon for insertion into the veins of a patient.

Formed integrally with and upstanding from cap 21 is an annular rib 27 forming a seat for a ball oat check rice valve 29, the latter being contained in section 15. Ball 29 may be formed of rubber, plastic, cork or any other suitable material having a specific gravity suiciently less than that of the liquid passing through the chamber so that ball 29 is buoyed up olf its seat by said liquid. It is apparent that the'inner walls of section 15 are so dimensioned as to conne lateral movement of ball 29 sufficiently to ensure its proper seating when the liquid supporting the same is exhausted. v

Formed across the upper end of section 15 is a web 31 centrally apertured and having an upstanding annular rim or rib 33 adapted to receive the lower end of a tubular filter member 35. Filter member 35 may be formed of a plastic fabric such as nylon, but, regardless of the material from which it is formed, it is formsustaining and sealed at its upper end as shown. l

In use, the device is incorporated in the intravenous solution administering set at a place between the intra venous solution reservoir or container and the patient, and may conveniently be incorporated as shown by having its opposite ends inserted into tubes leading to the reservoir or container and the patient. Cylinder 11 is vertically arranged and gas pressure is applied at the reservoir to force the intravenous solution through the administering set into cylinder v11 where it passes through lter 35 to have the clots and like matter ltered therefrom and passes down into section 15. Ball 29 is buoyed up olf its seat by the liquid, said liquid then passing down through nipple 23 and tube 25 toward the patient.

After liquid issues from the injection needle and all air has Ibeen removed from the set, said needle is injected into the patient and the administration of the intravenous solution proceeds at a rate determined by the force of gravity and the pressure of the gas. p

When the intravenous solution supply in the container or reservoir is exhausted, gas will travel down through tube 19 forcing the last increment of -solution therebefore into cylinder 11. However, as the solution is exhausted from section 15, iioat check valve 29 descends from the dot-dash line position shown in Fig. 1 and seats on valve seat 27 just before the complete exhaustion of solution from section 15, thereby serving to prevent gas from traveling down tube 25 toward the patient.

Fig. 2 shows a modified form of the invention wherein there is included an elongated cylindrical chamber 41 provided with a nipple or spike 43 at its upper end for insertion into a tube 45. Cylinder 41 is closed at its lower end by a cap 47 joined to said cylinder and centrally apertured for the passage of uid therethrough. Extending upwardly from cap 47 is an annular rib or rim 49 receiving the lower end of a tu'bular filter element 51 similar in construction to lilter element 35.

Depending from cap 47 is an annular rib or rim 53 receiving therewithin the larger upper end of a tapered tube 55, the lower end of which is preferably beveled and functions as an outlet nipple for insertion into a tube S7. Tube 57 leads to the patient. Contained within tube 55 is a ball oat check valve 59, similar to valve 29, and having a size such as to seat against the inner walls ofy tube 55 intermediate the length thereof when not suspended by a liquid.

The operation of this form of the invention is similar to that of the previously described form, ball 59 being buoyed up oi its seat by liquid within tube 55 (see the dot-dash lines in Fig. 2) and again seating upon substantial exhaustion of the liquid in said tapered tube to prevent the travel of gas down through outlet tube 57.

It is apparent that `by arranging the iilter element in each of the forms of the invention in a position above the valve structure, an arrangement has been provided for preventing clots and similar matter from detrimentally affecting the operation of the valve.

It will' therefore be seen that I have provided a device forming a component part ofV an intravenous solution administering set and functioning to allow the flow of liquid therethrough butpreventing the ow of gas throughA the outlet line connected thereto.

The particular form of oat check valve'shown` in the drawings is not intended. to limit my invention, since the valve may take many forms, and therefore the invention is intended to be limited only by the following claim.

Having thus described my invention,` what I claimv andv desire to secure by Letters Patent is:

An intravenous solution set component comprising a tubular chamber provided at its upper end with. an inlet seat formed in the lower end of said chamber; and a float check valve accommodated within the lower end of said chamber and operatively associated with said valve seat.

References Cited in the le of this patent UNITED STATES PATENTS 310,529 Lowrie rn. 6,. 118485 895,702 Wales Aug. l1, 1908 932,153 Martin Aug. 24, 1909 2,186,987 Nesset Aug. 5 19'38` 2,644,586 Cutter July '7, 1953 2,672,051S Butler' Mar. 16, 1954 FOREIGN PATENTS 115,599 Great Britain Mar. 16, 1918

Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US310529 *Jan 6, 1885 lowbie
US895702 *Aug 2, 1907Aug 11, 1908Royal L WalesSteam-trap.
US932153 *Sep 22, 1905Aug 24, 1909G A Julius MagerDispensing apparatus.
US2186987 *Aug 5, 1938Jan 16, 1940Baxter Laboratories IncFilter flow device
US2644586 *Aug 1, 1949Jul 7, 1953Cutter LabBlood strainer and drip meter
US2672051 *Oct 29, 1951Mar 16, 1954Cutter LabValved flow meter for parenteral solution injection sets
GB115599A * Title not available
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US3052238 *Apr 22, 1958Sep 4, 1962Baxter Laboratories IncPressure flow device
US3105511 *Aug 10, 1961Oct 1, 1963Cordis CorpInfusion safety valve
US4055176 *May 24, 1976Oct 25, 1977ValleylabUniversal drip chamber and spike assembly
US4087363 *Mar 22, 1976May 2, 1978Biotest-Serum-Institut GmbhFilter for blood
US4203463 *Apr 6, 1978May 20, 1980Jacques PonlotFlow-regulating device for perfusion-transfusion apparatus
US4267053 *Jun 20, 1979May 12, 1981Asahi Kasei Kogyo Kabushiki KaishaInline intravenous final filter unit
US4731056 *Nov 24, 1986Mar 15, 1988Cordis CorporationExternal drainage antisiphon device
US4842588 *Feb 1, 1988Jun 27, 1989Prd CorporationMethod of loading and discharging a drip chamber
US5423346 *Mar 3, 1994Jun 13, 1995Ivac CorporationFluid container shut off valve
US5707431 *Dec 18, 1996Jan 13, 1998Sims Level 1, Inc.Vortex gas elimination device
US5961700 *Oct 31, 1997Oct 5, 1999Sims Level 1Filter system for removal of gas and particulates from cellular fluids
US6695004Dec 16, 2002Feb 24, 2004Alaris Medical Systems, Inc.Magnetic automatic stop valve
EP0596260A1 *Oct 2, 1993May 11, 1994CLINICO INFUSIONSTECHNIK GmbHDevice for medical ozontherapy by transfusion or infusion
EP0676213A2 *Feb 15, 1995Oct 11, 1995Level 1 TechnologiesVortex gas elimination device
WO1999022840A1 *Oct 29, 1998May 14, 1999Sims Level 1 IncFilter system for removal of gas and particulates from cellular fluids
U.S. Classification137/192, 604/252, D24/129, 210/448, 604/254, 604/127, 137/399
International ClassificationA61M5/36, A61M5/40
Cooperative ClassificationA61M5/40
European ClassificationA61M5/40